4.0 Article

Carnitine and Metabolic Correlates in Hospitalized Psychiatric Patients: A Follow-Through Report

期刊

JOURNAL OF PSYCHIATRIC PRACTICE
卷 17, 期 1, 页码 35-40

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.pra.0000393842.63841.bc

关键词

carnitine; psychiatry; metabolic syndrome; lipids; cholesterol; glucose

向作者/读者索取更多资源

Background. Carnitine deficiency may be encountered in the context of chronic psychiatric illness, particularly with the chronic use of valproic acid. Despite the importance of carnitine in lipid metabolism and mitochondrial function, its metabolic effects have not been studied in a psychiatric population. Objective. To raise awareness regarding the possible metabolic implications of carnitine homeostasis in psychiatric patients. Method. Retrospective database review in a subgroup of 23 patients with documented hypo carnitinemia. Results. Statistical analysis revealed a negative correlation between serum carnitine levels and lipid levels. Initial fasting plasma glucose levels correlated positively with acylcarnitine/free carnitine ratios, suggesting unfavorable secondary effects of carnitine insufficiency, which resolved once carnitine was supplemented. Conclusion. Carnitine is a plausible substrate for future investigations of metabolic status in psychiatric patients. Further studies are needed to evaluate whether serum carnitine levels may be useful as a marker for psychiatric patients at risk for developing metabolic syndrome, and whether carnitine supplementation may reduce that risk. (Journal of Psychiatric Practice 2011;17:35-40)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry

Hans C. Lee, Karthik Ramasamy, Katja Weisel, Rafat Abonour, James W. Hardin, Robert M. Rifkin, Sikander Ailawadhi, Howard R. Terebelo, Brian G. M. Durie, Derek Tang, Prashant Joshi, Liang Liu, Ying-Ming Jou, Min Che, Gabriela Hernandez, Mohit Narang, Kathleen Toomey, Cristina Gasparetto, Lynne I. Wagner, Sundar Jagannath

Summary: This study evaluated the treatment patterns, survival, quality of life, and healthcare resource use among patients with triple-class refractory multiple myeloma (TCR MM) in US clinical practice. The findings highlight the substantial burden of TCR MM and the need for more effective treatment options.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)

Article Public, Environmental & Occupational Health

2gether: A Clinic-Based Intervention to Increase Dual Protection from Sexually Transmitted Infections and Pregnancy in Young African American Females

Melissa J. J. Kottke, Jessica M. M. Sales, Peggy Goedken, Jennifer L. L. Brown, Kendra Hatfield-Timajchy, Emilia H. H. Koumans, James W. W. Hardin, Joan Marie Kraft, Athena P. P. Kourtis

Summary: The 2gether intervention has been shown to be effective in increasing the use of condoms with contraception and reducing the rates of pregnancy and selected STIs among young African American females.

JOURNAL OF WOMENS HEALTH (2023)

Article Public, Environmental & Occupational Health

Relationship of Nonsteroidal Anti-Inflammatory Drug Use During Pregnancy with Autism Spectrum Disorder and Intellectual Disability Among Offspring

Mohiuddin Ahsanul Kabir Chowdhury, James W. Hardin, Bryan L. Love, Anwar T. Merchant, Suzanne McDermott

Summary: The study examined the association between nonsteroidal anti-inflammatory drug (NSAID) use during pregnancy and autism spectrum disorder (ASD) and intellectual disability (ID) in children. A retrospective cohort study was conducted using multiple datasets in South Carolina between 2010 and 2017. Results showed that NSAID use during pregnancy was associated with ID only, but not with ASD.

JOURNAL OF WOMENS HEALTH (2023)

Article Medicine, Research & Experimental

An overview of the together everyone achieves more physical activity (TEAM-PA) trial to increase physical activity among African American women

Allison M. Sweeney, Dawn K. Wilson, Nicole Zarrett, Pamela Martin, James W. Hardin, Amanda Fairchild, Sheryl Mitchell, Lindsay Decker

Summary: The TEAM-PA trial aims to test the effectiveness of a group intervention in increasing physical activity among insufficiently active African American women. The trial uses a group cohort design and involves 360 participants. The intervention integrates elements from various theories and focuses on social affiliation to evaluate its impact on physical activity.

CONTEMPORARY CLINICAL TRIALS (2023)

Letter Ophthalmology

Author Reply to Letter to the Editor: In Response to: Comment on Sutton et al.'s Allopurinol and the Risk of Diabetic Macular Edema among US Veterans with Type 2 Diabetes

S. Scott Sutton, Joseph Magagnoli, Tammy H. H. Cummings, James W. W. Hardin, Jayakrishna Ambati

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Article Ophthalmology

Allopurinol and the Risk of Diabetic Macular Edema among US Veterans with Type 2 Diabetes

S. Scott Sutton, Joseph Magagnoli, Tammy H. Cummings, James W. Hardin, Jayakrishna Ambati

Summary: By inhibiting xanthine oxidase, allopurinol may reduce the risk of diabetic macular edema (DME) by limiting inflammation and blood-retina barrier breakdown. A retrospective cohort study of type 2 diabetic US veterans found that allopurinol was associated with a 24.6% reduction in the risk of DME. Further research on the effects of allopurinol on DME is warranted.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Article Public, Environmental & Occupational Health

A qualitative study of ecological and motivational factors to inform weight management interventions for Black men in the rural South of the United States

Demetrius A. Abshire, Guillermo M. Wippold, Dawn K. Wilson, Bernardine M. Pinto, Janice C. Probst, James W. Hardin

Summary: This study conducted telephone interviews with 23 overweight or obese Black men in rural South Carolina communities to explore the factors that affect their motivation and weight-related behaviors, and to culturally adapt behavioral interventions for this population. Findings revealed that physical health and health behaviors were key determinants of overall health, and social support from family and friends both increased and hindered motivation. Younger participants expressed stronger views on the lack of support for healthy lifestyles in rural environments, along with personal challenges and lack of motivation.

SOCIAL SCIENCE & MEDICINE (2023)

Article Chemistry, Medicinal

Association between Fluoxetine Use and Overall Survival among Patients with Cancer Treated with PD-1/L1 Immunotherapy

Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, Tammy H. Cummings, James W. Hardin, S. Scott Sutton, Jayakrishna Ambati

Summary: A retrospective evaluation of cancer patients receiving checkpoint inhibitor therapy found that the combination of fluoxetine and checkpoint inhibitors could improve overall survival (OS).

PHARMACEUTICALS (2023)

Article Public, Environmental & Occupational Health

A Randomized Controlled Trial using Brief Educational Messages Directed to Adults with Intellectual Disability and Hypertension or their Helpers Reduces Hospital Stays

Wanfang Zhang, Suzanne McDermott, Deborah C. C. Salzberg, NaTasha D. D. Hollis, James Hardin

Summary: This study assessed an educational intervention aimed at reducing the number of emergency department and inpatient stays for cardiovascular diagnoses among South Carolina adult Medicaid members with intellectual and developmental disability and hypertension. The results of the randomized controlled trial showed significant reductions in hospital utilization in the intervention group compared to the control group.

AMERICAN JOURNAL OF HEALTH PROMOTION (2023)

Article Clinical Neurology

Periodontal Disease Treatment After Stroke or Transient Ischemic Attack: The PREMIERS Study, a Randomized Clinical Trial

Souvik Sen, James Curtis, David Hicklin, Cynthia Nichols, Saundra Glover, Anwar T. Merchant, James W. Hardin, Makenzie Logue, Jaclyn Meyer, Emma Mason, David Y. Huang, Cristiano Susin, Kevin Moss, James Beck

Summary: Intensive periodontal disease treatment was not superior to standard treatment in preventing stroke/myocardial infarction/death in patients with recent stroke/transient ischemic attack and periodontal disease. Fewer events were observed in the intensive arm with comparable safety outcomes. The secondary outcome measures showed a trend toward improvement, with significant changes noted in diastolic blood pressure and high-density lipoprotein in both treatment arms.

STROKE (2023)

Article Psychology, Multidisciplinary

Combining Inserts With Warning Labels on Cigarette Packs to Promote Smoking Cessation: A 2-Week Randomized Trial

James F. Thrasher, Stuart G. Ferguson, Emily E. Hackworth, Chung-Li Wu, Victoria C. Lambert, Norman Porticella, Minji Kim, James W. Hardin, Jeff Niederdeppe

Summary: Cigarette pack inserts with cessation messages may promote smoking cessation behaviors.

ANNALS OF BEHAVIORAL MEDICINE (2024)

Correction Cardiac & Cardiovascular Systems

Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate (Vol 56, pg 137, 2023)

S. Scott Sutton, Joseph Magagnoli, Tammy H. H. Cummings, Theresa Dettling, Belinda Lovelace, Mary J. J. Christoph, James W. W. Hardin

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2023)

Article Cardiac & Cardiovascular Systems

Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate

S. Scott Sutton, Joseph Magagnoli, Tammy H. Cummings, Theresa Dettling, Belinda Lovelace, Mary J. Christoph, James W. Hardin

Summary: Oral factor Xa inhibitors effectively reduce stroke and thromboembolic events in patients with atrial fibrillation or venous thromboembolism. However, due to the lack of a randomized controlled trial comparing andexanet alfa to usual care, non-specific replacement agents, including 4 F-PCC, are still used off-label for managing FXa inhibitor bleeds. A retrospective cohort study of 255 hospitalized patients exposed to oral factor Xa inhibitors and experiencing acute major bleeds found that those treated with andexanet alfa had significantly lower in-hospital and 30-day mortality rates compared to those treated with 4 F-PCC.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2023)

Article Primary Health Care

Odds of Achieving Target Serum Uric Acid Levels Among Gout Patients: The Role of Rurality in Outcomes and Treatment Adherence

S. Scott Sutton, Joseph Magagnoli, Tammy H. Cummings, James W. Hardin

Summary: The objective of this paper was to analyze patient outcomes in gout treatment and determine the differences in serum uric acid measures and treatment adherence among patients in metropolitan, micropolitan, or rural areas. The results showed that there was no significant difference in the proportion of patients achieving the target serum uric acid levels or treatment adherence between urban and rural patients.

JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2023)

Meeting Abstract Hematology

REAL-WORLD CLINICAL OUTCOMES AMONG US VETERANS WITH ORAL FACTOR XA INHIBITOR-RELATED MAJOR BLEEDING TREATED WITH ANDEXANET ALFA OR 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE

S. Scott Sutton, Joe Magagnoli, Tammy H. Cummings, Terry Dettling, James Hardin, Belinda Lovelace

AMERICAN JOURNAL OF HEMATOLOGY (2023)

暂无数据